{"protocolSection":{"identificationModule":{"nctId":"NCT04881162","orgStudyIdInfo":{"id":"SRM-2019-01"},"organization":{"fullName":"Silk Road Medical","class":"INDUSTRY"},"briefTitle":"Feasibility Study of the Treatment of Acute Ischemic Stroke Using the NOVIS Transcarotid Neuroprotection System","officialTitle":"Feasibility Study of the Treatment of Acute Ischemic Stroke Using the NOVIS Transcarotid Neuroprotection System In Transcarotid Embolectomy","acronym":"NITE1"},"statusModule":{"statusVerifiedDate":"2022-04","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-11-02","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2023-09","type":"ESTIMATED"},"completionDateStruct":{"date":"2023-12","type":"ESTIMATED"},"studyFirstSubmitDate":"2021-04-30","studyFirstSubmitQcDate":"2021-05-10","studyFirstPostDateStruct":{"date":"2021-05-11","type":"ACTUAL"},"lastUpdateSubmitDate":"2022-11-30","lastUpdatePostDateStruct":{"date":"2022-12-01","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Silk Road Medical","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":true,"isUnapprovedDevice":true},"descriptionModule":{"briefSummary":"Study Objective is to establish the feasibility and safety of the NOVIS Transcarotid Neuroprotection System when used for the transcarotid intervention of patients that have a failed transfemoral endovascular therapy in the case of anterior circulation strokes due to large vessel embolic occlusions.","detailedDescription":"This is a prospective, multi-center, single arm feasibility study for the endovascular treatment of patients with acute ischemic anterior circulation strokes due to large vessel embolic occlusions using the transcarotid approach with flow reversal. Patients enrolled into the NITE 1 Study will have failed transfemoral therapy and will be followed immediately from post-op to 90 days."},"conditionsModule":{"conditions":["Acute Ischemic Stroke"],"keywords":["mechanical thrombectomy","stroke treatment","embolic protection","transcarotid"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","interventionModelDescription":"Patients with acute ischemic anterior circulation stroke due to large vessel embolic occlusion who are candidates for endovascular therapy and in whom transfemoral therapy failed.","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":30,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"NOVIS Transcarotid Neuroprotection System (NPS)","type":"EXPERIMENTAL","description":"Patients that have failed transfemoral endovascular therapy in the case of anterior circulation strokes due to large vessel embolic occlusions will enrolled in the study and treated using the NOVIS Transcarotid NPS.","interventionNames":["Device: NOVIS Transcarotid Neuroprotection System (NPS)"]}],"interventions":[{"type":"DEVICE","name":"NOVIS Transcarotid Neuroprotection System (NPS)","description":"The NOVIS Transcarotid Neuroprotection System (NPS) is intended to provide transcarotid vascular access and embolic protection","armGroupLabels":["NOVIS Transcarotid Neuroprotection System (NPS)"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Device-related Serious Adverse Events","description":"Vascular complications including dissection, pseudoaneurysm, hematoma, arteriovenous fistula, thrombus formation, embolization and any vascular complication that may be attributed to the device AND requires surgical repair, surgical wound revision, transfusion, etc.","timeFrame":"procedure to 90 days"},{"measure":"Other Serious Adverse Events","description":"Permanent cranial nerve injury, new symptomatic ipsilateral hemorrhage and dissections related to ancillary devices","timeFrame":"procedure to 90 days"},{"measure":"Functional independence at 90-days","description":"modified Rankin scale score 0-2 (out of a maximum scale of 6. A lower score indicates better outcome, a higher score indicates worse outcome)","timeFrame":"90 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria Summary:\n\n* 1. Patients presenting with acute ischemic stroke of the anterior circulation with large vessel occlusions who are eligible for revascularization using endovascular therapies (stentrievers and/or aspiration devices)\n\n  2. Occlusion of the intracranial ICA, MCA M1, proximal MCA M2, single-vessel MCA M2, dominant MCA M2, or co-dominant MCA M2 segments\n\n  3. Patient has failed transfemoral therapy (see Appendix 4 for definition), and at least 15 minutes have elapsed from groin puncture\n\nExclusion Criteria Summary:\n\n* 1. Significant disease of the ipsilateral common carotid artery on routine CTA\n\n  2. Presence of a cervical ICA loop or other high-risk anatomical features of the ICA on routine CTA, that may preclude the use of the NOVIS NPS\n\n  3. Any active or recent hemorrhage within the past 30 days\n\n  4. Embolectomy contraindications\n\n  a. Pre-stroke mRS ≥2 b. NIHSS ≤ 5 c. ASPECTS ≤ 5\n\n  5. IV tPA has been or is being administered\n\n  6. Last known well \\> 24 hours ago","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Clinical Affairs Manager","role":"CONTACT","phone":"408-585-2142","email":"nhaque@silkroadmed.com"},{"name":"Senior Director Clinical Affairs","role":"CONTACT","phone":"669-271-0501","email":"dsahoo@silkroadmed.com"}],"overallOfficials":[{"name":"Charles Matouk, MD","affiliation":"Yale University","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Yale University","status":"RECRUITING","city":"New Haven","state":"Connecticut","zip":"06511","country":"United States","contacts":[{"name":"Lindsey Fraczkiewicz","role":"CONTACT","phone":"203-785-3490","email":"lindsey.fraczkiewicz@yale.edu"}],"geoPoint":{"lat":41.30815,"lon":-72.92816}}]},"ipdSharingStatementModule":{"ipdSharing":"NO","description":"IPD will not be shared"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}